Science Explorer Back to mapMap
Discussion
Company · Charlottesville · United States

Adenosine Therapeutics (United States)

adenrx.com/index.htmlROR OpenAlex
Research works
25
▼ 88% vs 2018-21
Citations
1.2k
47.2 per fractional work
Top-10% rate
7.1%
all institutions 10.0%
Open access
47%
world 40%
International
17%
world 18%
Adenosine Therapeutics (United States)

Not ranked overall: Adenosine Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Adenosine Therapeutics (United States) work in?

In all years, 52% of research at Adenosine Therapeutics (United States) is in Life Sciences, 41% in Health Sciences. Its largest fields are Medicine (41%), Biochemistry, Genetics and Molecular Biology (39%), Neuroscience (9%). It does 2.4× the world's share of Life Sciences.

Life Sciences: 13 fractional works · 52.4% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 38.9% of its workMolecular Biology: 8 fractional works · 29.9% of its workPhysiology: 2 fractional works · 6.3% of its workCell Biology: 0 fractional works · 1.3% of its workGenetics: 0 fractional works · 1.3% of its workNeuroscience: 2 fractional works · 9.4% of its workCellular and Molecular Neuroscience: 1 fractional works · 5.4% of its workSensory Systems: 0 fractional works · 1.3% of its workNeurology: 0 fractional works · 1.2% of its workBiological Psychiatry: 0 fractional works · 1.0% of its workDevelopmental Neuroscience: 0 fractional works · 0.4% of its workImmunology and Microbiology: 1 fractional works · 2.8% of its workImmunology: 1 fractional works · 2.8% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.3% of its workPharmacology: 0 fractional works · 1.3% of its workHealth Sciences: 10 fractional works · 41.4% of its workMedicine: 10 fractional works · 41.4% of its workPhysiology: 2 fractional works · 9.7% of its workNeurology: 2 fractional works · 6.3% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 4.0% of its workPsychiatry and Mental health: 1 fractional works · 3.5% of its workSurgery: 1 fractional works · 2.8% of its workGenetics: 1 fractional works · 2.8% of its workOncology: 1 fractional works · 2.6% of its workPathology and Forensic Medicine: 0 fractional works · 1.7% of its workPharmacology: 0 fractional works · 1.5% of its workBiochemistry: 0 fractional works · 0.7% of its workGastroenterology: 0 fractional works · 0.7% of its workHematology: 0 fractional works · 0.7% of its workObstetrics and Gynecology: 0 fractional works · 0.7% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.7% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.7% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.7% of its workRheumatology: 0 fractional works · 0.7% of its workEpidemiology: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workPhysical Sciences: 1 fractional works · 4.9% of its workComputer Science: 0 fractional works · 1.3% of its workComputational Theory and Mathematics: 0 fractional works · 1.3% of its workEnergy: 0 fractional works · 1.3% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 1.3% of its workEngineering: 0 fractional works · 1.3% of its workBiomedical Engineering: 0 fractional works · 1.3% of its workMaterials Science: 0 fractional works · 0.7% of its workBiomaterials: 0 fractional works · 0.7% of its workChemistry: 0 fractional works · 0.3% of its workOrganic Chemistry: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 1.3% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.3% of its workEconomics and Econometrics: 0 fractional works · 1.3% of its workALL ITS WORKAdenosineTherapeutics…25fractional works, all years
Life Sciences52%Physical Sciences5%Health Sciences41%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1038.9%
    2. Neuroscience29.4%
    3. Immunology and Microbiology12.8%
    4. Pharmacology, Toxicology and Pharmaceutics01.3%
    1. Medicine1041.4%
    1. Computer Science01.3%
    2. Energy01.3%
    3. Engineering01.3%
    4. Materials Science00.7%
    5. Chemistry00.3%
    1. Economics, Econometrics and Finance01.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Adenosine Therapeutics (United States)?

The most cited paper from Adenosine Therapeutics (United States) is "A2A Adenosine Receptor Induction Inhibits IFN-γ Production in Murine CD4+ T Cells" (Courtney M. Lappas, Jayson M. Rieger, Joel M Linden, 2005), with 386 citations. Next come "Neuroinflammation in Alzheimer’s Disease" (323) and "Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer’s Disease" (142).

Most cited papers
#PaperReleasedCitations
1 A2A Adenosine Receptor Induction Inhibits IFN-γ Production in Murine CD4+ T Cells Courtney M. Lappas, Jayson M. Rieger, Joel M Linden · The Journal of Immunology Open access 2005 386
2 Neuroinflammation in Alzheimer’s Disease Isaac G. Onyango, Gretsen Velezmoro Jáuregui, Mária E. Čarná et al. · Biomedicines Open access 7 May 2021 323
3 Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer’s Disease Shreaya Chakroborty, Clark A. Briggs, Megan B. Miller et al. · PLoS ONE Open access 21 Dec 2012 142
4 The A2B Adenosine Receptor Impairs the Maturation and Immunogenicity of Dendritic Cells Jeffrey M. Wilson, William G. Ross, Oma N. Agbai et al. · The Journal of Immunology Open access Apr 2009 136
5 Links Between Insulin Resistance, Adenosine A2B Receptors, and Inflammatory Markers in Mice and Humans Robert A. Figler, Guoquan Wang, Susseela Srinivasan et al. · Diabetes Open access 21 Jan 2011 120
All 45 most cited papers, with filters and sorting

Which keywords describe research at Adenosine Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Oxidative Stress, Neurodegeneration, Inflammation, Mitochondrial Dysfunction, Ion Channels, Reactive Oxygen Species, Cell Signaling and Membrane Proteins.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 29 words, with their numbers
  1. Oxidative Stress5▲ 10×9 topics
  2. Inflammation4▲ 5.9×11 topics
  3. Neurodegeneration3▲ 43×6 topics
  4. Mitochondrial Dysfunction3▲ 28×6 topics
  5. Cell Signaling2▲ 28×2 topics
  6. Ion Channels2▲ 44×3 topics
  7. Reactive Oxygen Species2▲ 19×4 topics
  8. Membrane Proteins2▲ 44×2 topics
  9. Calcium Channels2▲ 103×1 topic
  10. Neuroinflammation2▲ 27×4 topics
  11. Neuroprotection2▲ 20×3 topics
  12. Voltage-Gated Channels2▲ 103×1 topic
  13. Tumor Microenvironment2▲ 20×2 topics
  14. Aging2▲ 13×2 topics
  15. Metabolic Regulation2▲ 24×2 topics
  16. Adenosine Receptors2▲ 250×1 topic
  17. Cell Death2▲ 30×3 topics
  18. Neurodegenerative Diseases2▲ 30×4 topics
  19. Purinergic Signalling2▲ 250×1 topic
  20. Mitochondria1▲ 34×2 topics
  21. Mitochondrial Fission1▲ 71×1 topic
  22. Mitochondrial Fusion1▲ 71×1 topic
  23. Amyloid Hypothesis1▲ 97×1 topic
  24. Tau Pathology1▲ 97×1 topic
  25. Genetics1▲ 5.9×4 topics
  26. Synaptic Plasticity1▲ 15×4 topics
  27. Depression1▲ 5.7×4 topics
  28. Crystal Structure1▲ 16×2 topics
  29. Parkinson's Disease1▲ 17×3 topics

Which research topics does Adenosine Therapeutics (United States) publish most on?

By volume in 2022-now: Neurogenetic and Muscular Disorders Research, RNA Research and Splicing, Bone and Joint Diseases and Trypanosoma species research and implications.

Neurogenetic and Muscula…0Neurogenetic and Muscular Disorders Research: 0 fractional worksRNA Research and Splicing0RNA Research and Splicing: 0 fractional worksBone and Joint Diseases0Bone and Joint Diseases: 0 fractional worksTrypanosoma species rese…0Trypanosoma species research and implications: 0 fractional worksCarbohydrate Chemistry a…0Carbohydrate Chemistry and Synthesis: 0 fractional worksLysosomal Storage Disorders Research: 0 fractional works
GeneticsMolecular BiologyOrthopedics and Sports MedicineEpidemiology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Neurogenetic and Muscular Disorders Research Genetics 0 works
  2. 2 RNA Research and Splicing Molecular Biology 0 works
  3. 3 Bone and Joint Diseases Orthopedics and Sports Medicine 0 works
  4. 4 Trypanosoma species research and implications Epidemiology 0 works
  5. 5 Carbohydrate Chemistry and Synthesis Organic Chemistry 0 works
  6. 6 Lysosomal Storage Disorders Research Physiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.2%not open52.8%

World: 40% of research is openly available.

with international co-authors16.9%domestic only83.1%

World: 18% is written across borders.

How has Adenosine Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 88% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Adenosine Therapeutics (United States) as a percentage of every work published that year, 0.0000036% in 2024.

still counting0.000050%0.00010%0.00015%Adenosine Therapeutics (United States)0.0000085% in 2025200020102020

Fractional works of Adenosine Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Charlottesville

All research institutions in Charlottesville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Adenosine Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.